Medacta Group (XSWX:MOVE) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:MOVE Medacta Group SA XSWX:MOVE
85 GF Score
Price CHF132.80
GF Value CHF171.23
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medacta Group Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XSWX:MOVE
85GF Score
Medacta Group SA XSWX:MOVE
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medacta Group (XSWX:MOVE) Overvalued in 2026?

Based on GuruFocus' analysis, Medacta Group stock appears to be undervalued. The current stock price of CHF132.80 is trading 22.4% below its estimated GF Value™ of CHF171.23. GuruFocus considers Medacta Group to be Modestly Undervalued.

Key valuation signals for XSWX:MOVE:

  • Short Ratio:
  • GF Value™: CHF171.23 vs. price of CHF132.80 (22.4% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the XSWX:MOVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medacta Group Business Description

Other Exchanges MOVEz:UK0A05:UK6MD:Germany
Address Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is involved in developing, manufacturing, and distributing orthopedic and neurosurgical medical devices. It specializes in the design, production, and distribution of personalized and sustainable solutions for joint replacement, sports medicine, and spine surgery. Medacta's product portfolio includes hip, knee, shoulder, and spine replacement solutions, along with a comprehensive range of sports medicine. Its products and surgical techniques are supported by an extensive program of surgeon education and engagement initiatives, enabling its offerings to be effective for the patient and surgeon. Geographically, the company derives maximum revenue from EMEA (which includes Europe, Middle East and Africa), followed by North America, Asia-Pacific, and the Latin America markets.
85GF Score

Get the complete analysis for XSWX:MOVE

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF132.80
Price
CHF171.23
GF Value